RANIBIZUMAB

UNII:	ZL1R02VT79
Formula:
Preferred Substance Name:	RANIBIZUMAB

347396-82-1
BYOOVIZ
CIMERLI
FAB-12 VARIANT Y0317
FYB201
FYB-201
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR) FAB FRAGMENT (HUMAN-MOUSE MONOCLONAL RHUFAB V2 1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL RHUFAB V2 LIGHT CHAIN
PF582
PF-582
PF-582 (RANIBIZUMAB BIOSIMILAR)
RANIBIZUMAB [EMA EPAR]
RANIBIZUMAB [INN]
RANIBIZUMAB [JAN]
RANIBIZUMAB [MART.]
RANIBIZUMAB [MI]
RANIBIZUMAB [PURPLE BOOK CDER]
RANIBIZUMAB [USAN]
RANIBIZUMAB [VANDF]
RANIBIZUMAB [WHO-DD]
RANIBIZUMAB BIOSIMILAR PF582
RANIBIZUMAB NUNA [WHO-DD]
RANIBIZUMAB-EQRN
RANIBIZUMAB-NUNA
RBZ
RG-3645
RHUFAB
SUSVIMO

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RANIBIZUMAB

Synonyms and Mappings

Resources